Skip to content
Disclosery

EXANE DERIVATIVES: FSRNQ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FSRNQ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 50,000 FSRNQ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 50,000 shares
    Change vs previous 13F +50,000 shares

    0.25% of the 13F portfolio, value $428,413.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2021-12-31
    13F 0 shares
    Change vs previous 13F -38,300 shares

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  3. period ended2021-09-30
    13F 38,300 shares
    Change vs previous 13F +19,012 shares

    0.14% of the 13F portfolio, value $561,075.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 19,288 shares
    Change vs previous 13F -12,612 shares

    0.07% of the 13F portfolio, value $315,737.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 31,900 shares
    Change vs previous 13F not available

    0.17% of the 13F portfolio, value $549,294.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).